Log in
Enquire now
Guide Therapeutics, Inc.

Guide Therapeutics, Inc.

Guide Therapuetics, Inc. was founded in 2018 in Tucker, Georgia.

OverviewStructured DataIssuesContributors

Contents

guiderx.com
guidetx.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Engineering
Engineering
Biomedical engineering
Biomedical engineering
Therapeutics
Therapeutics
Location
Tucker, Georgia
Tucker, Georgia
B2X
B2B
B2B
CEO
‌
Thomas Saylor
Founder
Cory Sago
Cory Sago
James Dahlman
James Dahlman
‌
Thomas Saylor
Legal Name
Guide Therapeutics, Inc.
Legal classification
Corporation
Corporation
Date Incorporated
2018
Number of Employees (Ranges)
11 – 50
Full Address
1860 Montreal Rd Tucker, GA 30084
CIK Number
1,769,132
Place of Incorporation
Delaware
Delaware
Founded Date
2018
Total Funding Amount (USD)
18,862,139
Latest Funding Round Date
August 2020
Latest Funding Type
‌
Venture round
Country
United States
United States

Other attributes

Company Operating Status
Active

Guide Therapeutics, Inc. is a company that patents technologies to test thousands of chemically distinct nanoparticles in vivo. It enables the business to identify simple, scalable, and clinically relevant nanoparticles that target new cell types efficiently and safely.This technology utilizes DNA barcodes, which are DNA sequences that are rationally designed to act as molecular tags for specific nanoparticles.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Guide Therapeutics, Inc.

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Become an Editor
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.